RECITALSLoan and Security Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • California
AGREEMENT ON MANUFACTURING, SALES AND DISTRIBUTION LICENSE FOR HMRLIGNAN(TM) made this 8th day of April 2005 (hereinafter referred to as the "Agreement") By and between LINNEA S.A. ("LINNEA") Via Cantonale, 6595 Riazzino (Locarno) Switzerland andAgreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations
Exhibit 10.6 FIRST AMENDMENT TO LEASE THIS FIRST AMENDMENT TO LEASE ("First Amendment") is made as of June 30, 2005, by and between TRANSWESTERN GREAT LAKES, L.P., a Delaware limited partnership ("Landlord"), and QUATRX PHARMACEUTICALS COMPANY, a...Lease • February 3rd, 2006 • Quatrx Pharmaceuticals Co
Unofficial translation LEASE AGREEMENT LESSOR Turun Biolaakso Oy Lemminkaisenkatu 14-18 A, 20520 Turku Business ID 1485010-2 Domicile Turku LESSEE Hormos Medical Oy Tykistokatu 6 A, 20520 Turku Trade reg. no. 705.643 Domicile Turku LEASE OBJECT...Lease Agreement • February 3rd, 2006 • Quatrx Pharmaceuticals Co
Exhibit 4.4 THESE SECURITIES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933 AS AMENDED, OR ANY STATE SECURITIES LAWS. THEY MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED, OR HYPOTHECATED EXCEPT IN ACCORDANCE WITH THE SECURITIES ACT OF 1933 ACT...Warrant Agreement • February 3rd, 2006 • Quatrx Pharmaceuticals Co • Delaware
RECITALSEscrow Agreement • February 3rd, 2006 • Quatrx Pharmaceuticals Co • New York
RECITALSIndemnification Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • Delaware
RECITALSExchange Agreement • February 3rd, 2006 • Quatrx Pharmaceuticals Co • New York
RECITALSInvestors' Rights Agreement • February 3rd, 2006 • Quatrx Pharmaceuticals Co • Delaware
EXHIBIT 10.15 PATENT LICENSE AGREEMENT This Agreement (hereinafter the "Agreement") is made this 10th day of October, 2005 (hereinafter "Date of Agreement") by and between Hormos Medical Corporation a corporation duly organized and existing under the...Patent License Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations
EXHIBIT 10.12Exclusive License Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • New York
Exhibit 10.16 RESTATED TRANSFER AGREEMENT (hereinafter referred to as the "Agreement") Made this 26th day of May 2005 (the "Effective Date")Transfer Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • New York
Common StockUnderwriting Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • New York
AGREEMENT ON MANUFACTURING, SALES AND DISTRIBUTION LICENSE FOR HMRLIGNAN(TM) made this 8th day of April 2005 (hereinafter referred to as the "Agreement") By and between LINNEA S.A. ("LINNEA") Via Cantonale, 6595 Riazzino (Locarno) Switzerland andAgreement • February 3rd, 2006 • Quatrx Pharmaceuticals Co
EXECUTION COPY EXCLUSIVE LICENSE AGREEMENT THIS EXCLUSIVE LICENSE AGREEMENT (this "Agreement") is entered into on the 14th day of February 2005, by and between EndoChem, Inc., a corporation organized and existing under the laws of the State of...Exclusive License Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • California
PATENT LICENSE AGREEMENT This Agreement (hereinafter the "Agreement") dated __________________________, 2004 (hereinafter "Date of Agreement") by and betweenPatent License Agreement This Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations
EXHIBIT 10.7Exclusive License Agreement • April 20th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • Michigan
AGREEMENT ---------Agreement • April 4th, 2006 • Quatrx Pharmaceuticals Co • Pharmaceutical preparations • Wisconsin
Issaquah, WA 98029 This letter ("Agreement") sets forth terms and conditions which will apply to your performance of services for QuatRx Pharmaceuticals Company ("QuatRx"), which will commence November 1, 2003. You and QuatRx acknowledge as follows:...Quatrx Pharmaceuticals Co • February 3rd, 2006
AMENDMENT NO. 1 TO THE EXCLUSIVE LICENSE AGREEMENTThe Exclusive License Agreement • February 3rd, 2006 • Quatrx Pharmaceuticals Co
THIS AGREEMENT ON DEVELOPMENT OF THE SYNTHESIS OF FC-1271A AND MANUFACTURING OPTIONQuatrx Pharmaceuticals Co • April 4th, 2006 • Pharmaceutical preparations
Exhibit 10.17 CONFIDENTAL PATENT ASSIGNMENT AGREEMENT This agreement (hereinafter "Agreement") is made and effective on the 4th day of June, 2004 ("Date of the Agreement") and entered into and between HORMOS MEDICAL CORPORATION PharmaCity, Itainen...Patent Assignment Agreement • February 3rd, 2006 • Quatrx Pharmaceuticals Co
Exhibit 10.8 Confidential Treatment Requested (QUATRX LOGO) QUATRx Pharmaceuticals Company Chris I. Nicholas 5430 Data Court, Suite 300 Ann Arbor, MI 48108 (734) 9134900 * fax (134) 913.0743 www.quatrx.com - email cnicholas@quartx.com CONFIDENTIAL...Quatrx Pharmaceuticals Co • February 3rd, 2006
Exhibit 10.3 PEGASUS PHARMACEUTICALS COMPANY 2000 EQUITY INCENTIVE PLAN AS ADOPTED DECEMBER 19, 2000 ARTICLE 1. DEFINITIONS. As used in this Plan, the following terms will have the following meanings: 1.1. "AWARD" means any award under this Plan,...Quatrx Pharmaceuticals Co • February 3rd, 2006 • Delaware
